Actavis sales and marketing update

Actavis launched Avycaz ceftazidime/ avibactam in the U.S. to treat adults with complicated intra-abdominal infections (cIAI) and complicated urinary tract infections (cUTI) and have no or limited treatment options. The wholesale acquisition cost (WAC) for a package of 10 vials containing 2.5 g Avycaz is $2,850. The recommended dose is 2.5 g every eight hours. The recommended treatment duration is five to 14 days for cIAIs and seven to 14 days for uUTIs. ...